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Thiamine is an essential micronutrient that plays a key role in energymetabolism.Many populations worldwidemay
be at risk of clinical or subclinical thiamine deficiencies, due to famine, reliance on staple crops with low thiamine
content, or food preparation practices, such as milling grains and washing milled rice. Clinical manifestations of
thiamine deficiency are variable; this, along with the lack of a readily accessible and widely agreed upon biomarker
of thiamine status, complicates efforts to diagnose thiamine deficiency and assess its global prevalence. Strategies
to identify regions at risk of thiamine deficiency through proxy measures, such as analysis of food balance sheet
data and month-specific infant mortality rates, may be valuable for understanding the scope of thiamine deficiency.
Urgent public health responses are warranted in high-risk regions, considering the contribution of thiamine defi-
ciency to infant mortality and research suggesting that even subclinical thiamine deficiency in childhood may have
lifelongneurodevelopmental consequences. Food fortification andmaternal and/or infant thiamine supplementation
have proven effective in raising thiamine status and reducing the incidence of infantile beriberi in regions where
thiamine deficiency is prevalent, but trial data are limited. Efforts to determine culturally and environmentally
appropriate food vehicles for thiamine fortification are ongoing.
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Purpose statement
In January and March 2017, the Sackler Institute
for Nutrition Science at the New York Academy of
Sciences and the Bill & Melinda Gates Foundation
convened a technical consultation to explore the
global prevalence and disease burden of thiamine
deficiency. Participants with expertise in micronu-
trient malnutrition, pediatrics, biochemistry,
neurology, and public health supplementation and
fortification programs presented research findings
and participated in discussion groups with the goal
of determining the best biomarkers of thiamine
status, estimating the global prevalence of thiamine
deficiency, devising strategies for increasing thi-
amine status, and identifying research needs. The
group’s longer term objective is to improve the
control of thiamine deficiency, including achieving
consensus on diagnostic criteria, establishing better
data on the global burden of disease, and expanding
effective intervention strategies.
The following paper describes the current state of
thiamine research and the significance of thiamine
deficiency in low- and middle-income countries
(LMIC) from public health and clinical perspec-
tives, as well as a summary of the consultation
group’s discussions and conclusions.
Thiamine biology
Thiamine, also called vitamin B1, is an essential
micronutrient. The human body’s supply of
thiamine depends almost entirely on dietary intake;
there is no endogenous synthesis, though some
forms of bacteria in the intestine can produce a
small amount of thiamine.1 Thiamine has a short
half-life (1−12 h) and body stores are limited; thus,
a regular dietary supply is required to maintain
tissue thiamine levels.2,3 The richest food sources of
thiamine are whole grains, yeasts, meats, legumes,
and nuts. In many high-income countries, wheat
flour, cereals, and infant formulae are fortified
with thiamine; thiamine-fortified foods contribute
about half of the total amount of the vitamin
consumed in these settings.4 In LMIC where thi-
amine fortification is less common, a lack of dietary
diversity and reliance on low-thiamine staple foods
are leading causes of thiamine deficiency.
Thiamine is present in the body as free thiamine,
as well as in several phosphorylated forms: thiamine
monophosphate (ThMP), thiamine diphosphate
(ThDP), and thiamine triphosphate (ThTP)
(reviewed in Refs. 5–7). The different forms of
thiamine detectable in plasma or whole blood are
shown in Table 1.8 ThDP, also called thiamine
pyrophosphate, is the metabolically active form,
constituting some 80% of total body thiamine.
ThDP is an essential cofactor in multiple enzyme
complexes involved in the metabolism of carbo-
hydrates and amino acids (Fig. 1).9 These enzyme
complexes include the pyruvate dehydrogenase
complex (which converts pyruvate to acetyl-CoA),
the -ketoglutarate dehydrogenase complex (which
converts -ketoglutarate to succinyl-CoA), and
the branched chain -keto acid dehydrogenase
complex (which converts branched chain -keto
acids to the corresponding acyl-CoAs).
ThDP is also a cofactor of cytosolic transke-
tolase in the pentose phosphate pathway and of
2-hydroxyacyl-CoA lyase, a peroxisomal enzyme
involved in -oxidation of phytanic acid. It seems
that the -ketoglutarate dehydrogenase is most
sensitive to thiaminedeficiency, and reducedactivity
of this enzyme complex can quickly lead to reduced
ATP synthesis, oxidative damage, and, ultimately,
cell death (Fig. 2).10 Thiamine circulates in theblood
primarily in erythrocytes and is delivered to cells
with highmetabolic need, notably cells in the brain,
liver, pancreas, heart, and skeletal and smoothmus-
cles, including cardiac myocytes.
The recommended nutrient intake (RNI) of
thiamine is 1.2 mg/day for men and 1.1 mg/day for
women, and increases to 1.4 mg/day for pregnant
and 1.5 mg/day for lactating women. In infancy, the
adequate intake is set at 0.2 mg/day (0−6 months)
and 0.3 mg/day (7−12 months). The RNI gradually
increases to 0.5 mg/day for children ages 1−3 years,
0.6 mg/day 4−6 years, and 0.9 mg/day by ages 7−9
years. After age 10, children’s thiamine requirement
is the same as for adults. There are no known
adverse effects of high thiamine intakes; and there
is no upper intake level for thiamine.11
Biomarkers for assessing thiamine status
Thiamine status can be evaluated in two ways,
by assessing the degree of ThDP-saturation
of a thiamine-dependent enzyme (erythrocyte
transketolase (ETK) assay), and by measuring
thiamine metabolites in accessible tissues. The ETK
assay is considered to be more informative, as it
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Table 1. Distribution of thiamine derivatives in human whole blood and plasma in nmol/L ± standard deviation
with the percent of total thiamine derivatives in each specimen type
Specimen (n) Thiamine (nmol/L) ThMP (nmol/L) ThDP (nmol/L) ThTP (nmol/L)
Whole blood (7) 4 ± 3 (2.4%) 10 ± 4 (6.1%) 138 ± 33 (83.6%) 13 ± 4 (7.9%)
Plasma (3) 11 ± 3 (68.7%) 5 ± 2 (31.3%) n.d. n.d.
ThMP, thiamine monophosphate; ThDP, thiamine diphosphate; ThTP, thiamine triphosphate; n.d., not detectable.
Adapted from Gangolf et al.8
demonstrates actual functionality of the vitamin.
Table 2 lists the most relevant thiamine biomarkers
with their advantages and disadvantages. Both
methods show thiamine status to be lower in
regions of the world where beriberi occurs than
where it does not occur. However, in populations
with beriberi, both affected and nonaffected
individuals may have similarly low values.12,13
Thiamine esters and other metabolites are found in
blood and urine. Whole blood total thiamine (i.e.,
free thiamine plus its esters) typically ranges from
75 to 195 nmol/L, most of which is present as ThDP
(70−180 nmol/L).14 The rate of ThDP depletion in
erythrocytes is similar to that of other organ tissues,
and it is well correlated with dietary intake.9,15
Analysis of thiamine diphosphate
Analysis of ThDP in whole blood or erythrocytes
can be a useful biomarker of thiamine status.14
The majority (80%) of the total thiamine con-
tent of whole blood is present in erythrocytes as
ThDP. Whole blood or erythrocyte ThDP (eThDP)
concentration is reflective of body stores and pro-
vides a better measure of thiamine status than total
thiamine. However, direct measurement of
ThDP does not assess thiamine metabolic
function.
The expected concentration of ThDP in whole
blood is approximately 70−180 nmol/L for
healthy individuals, though there is no universally
accepted cutoff value for thiamine deficiency,
Figure 1. Thiamine diphosphate is a cofactor required for several metabolic processes, shown in bold text. Adapted from
Thurnham.9
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Figure 2. The three thiamine-dependent enzymes and their role in the pathogenesis of cell death in thiamine deficiency. Adapted
from Fattal-Valevski.10 Dashed lines represent indirect pathways. ThDP, thiamine diphosphate.
and a wide range of cutoffs have been used.14,16
Thiamine metabolites can be determined by
high-performance liquid chromatography (HPLC)
with ultraviolet-visible spectroscopy (UV/VIS) or
fluorescence detection.14,17,18 Thiamine is excreted
in urine, chiefly as free thiamine and ThMP, with
smaller amounts of ThDP and more than 20
other metabolites, including the oxidation product
thiochrome. Urinary losses of thiamine metabolites
vary with plasma thiamine concentrations, increas-
ing markedly when renal tubular reabsorption is
saturated, which occurs in healthy adults at intakes
of 0.3−0.4 mg thiamine per 1000 kcal.19 Above
that threshold, excretion of the vitamin exceeds
100 g/day, whereas urinary excretion in deficient
individuals is<25g/day. Increased concentrations
of both pyruvate and -ketoglutarate in whole
blood or plasma, and of methylglyoxal in the urine
and cerebrospinal fluid, also occur in thiamine
deficiency.
Table 2. Thiamine biomarkers used to measure recent intake and thiamine status
Biomarker Specimen Advantages Disadvantages
Direct measurement
Thiamine Plasma Indicates recent intake Not an indicator of thiamine
status
ThMP Plasma Indicates recent intake Not an indicator of thiamine
status
ThDP Whole blood; erythrocytes Biologically active vitamer and
indicator of thiamine status
Unstable if specimen is not
properly handled
Indirect/functional measurement
ETK activity coefficient Washed erythrocytes Functional assay of biological
activity
Assay is not readily available
ThMP, thiamine monophosphate; ThDP, thiamine diphosphate; ETK, erythrocyte transketolase.
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Sample type. ThDP can be measured in ery-
throcytes; however, whole blood is a more prac-
tical specimen. Whole blood ThDP concentration
has been shown to correlate with eThDP concen-
tration and obviates the need for separating and
washing erythrocytes.17 ThDP can be measured
in venous blood collected into ethylenediaminete-
traacetic acid (EDTA)– or heparin-containing spec-
imen tubes.When erythrocytes are analyzed instead
of whole blood, the cells must be washed with
saline before testing in a process that is cumber-
some and time-consuming, andmaydecrease ThDP
concentration.20 Thus, using whole blood as a sam-
ple matrix shortens analysis time and simplifies
sample preparation.
Analyticalmethods. Individual thiamine species,
includingThDP, can bemeasured directly using sev-
eral techniques. HPLC with either pre- or post-
column derivatization coupled with fluorescence
detection has been available for several decades and
is the most common method in current use.21 In
this method, samples are prepared by removal of
proteins and derivatization to produce fluorescent
thiochrome compounds that are separated on a
reverse phase analytical column, then detected and
quantified.14
Methods usingmass spectrometry have also been
developed.18 Liquid chromatography coupled to
tandem mass spectrometry (LC–MS/MS) allows
sensitive and selective measurement of underiva-
tized ThDP. LC–MS/MS methods require smaller
sample volumes and are faster, but the instruments
are more expensive than an HPLC with an optical
detector.
Data analysis and presentation. Since there are
no standard reference ranges currently accepted for
ThDP, the data should be presented with the ref-
erence interval used by the reporting laboratory.
For erythrocytes, ThDP concentrations should be
reported in nmol/L red blood cells (RBCs). For
whole blood, there is a need to normalize to RBC
volume or hemoglobin concentrations.22 For these
data, best practice would be to present both the
measured ThDP (nmol/L whole blood) and the
ThDP normalized to hematocrit (nmol/L RBC) or
hemoglobin (nmol/gram hemoglobin). This will
help ensure that data fromdifferent studies are com-
parable, and hematocrit or hemoglobin normalized
whole blood data could be directly compared with
eThDP concentrations. Historically, some data have
been presented as g/L but to make data between
studies more readily comparable, it is suggested to
use nmol/L.
Challenges and limitations of ThDP assessment.
Preanalytical: Specimens should be protected from
light and stored cold. Thiamine is stable for a few
hours refrigerated and for several months stored
frozen (–20 to –80 °C).14
1. Thiamine compounds are photosensitive, and
must be stored in the dark;
2. They are also labile compounds requiring
careful procedures for sample collection,
transport, and storage at least –20 °C to avoid
spontaneous hydrolysis;
3. Specimens of whole blood must be frozen to
ensure lysis of erythrocytes.
Analytical:
1. Chromatographic separation of thiamine
metabolites is necessary for analysis by HPLC
with optical detection; this is not necessary for
determination by mass spectrometry.
2. Calibration using an internal standard to
account for losses during sample prepara-
tion, while desirable, is rarely used due to the
lack of appropriate thiamine standards useful
for HPLC/fluorescence methods. Isotopically
labeled internal standards are available for
LC–MS/MS methods.
3. Analytical methods have not been stan-
dardized. Considerable variation has been
observed between laboratories.23
Analysis of erythrocyte transketolase activity
The functional assessment of thiamine status
was developed more than 50 years ago, using the
response of the ThDP-dependent enzyme trans-
ketolase in erythrocyte hemolysates to exogenous
ThDP.15 Erythrocyte transketolase (ETK) activity is
suboptimalwhen thiamine intake, andhence, ThDP
supply, is low. Therefore, the change in ETK activity
upon the addition of exogenous saturating amounts
of ThDP is indicative of thiamine functional status.
Sample type. Washed, anticoagulated (lithium
heparin– or EDTA-containing tubes) erythrocytes
are used for this assay. Erythrocytes are washed
with isotonic saline solution (0.9% NaCl) to avoid
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osmotic damage to the cells; standard procedure
involves three cycles of washing, centrifugation,
removal of supernatant and the top fewmmof cells,
and resuspension in saline. The washed cells, with-
out supernatant, are frozen at –70 °C or colder and
are osmotically lysed after thawing by resuspending
inwaterbefore analysis.Theassay requiresonly a few
microliters of washed erythrocytes; sample volume
requirement is governed by the amounts needed to
complete thewashing, lysis, and subsequentdilution
steps.
Analytical methods. The assay of ETK activity
coefficient (Fig. 3) canbe performed conveniently in
a UV-transparent 96-well microplate, with param-
eters matched to the Cobas Bio assay.24 All wells
must be held at the same temperature, 37 °C,
and all reagents must be in excess throughout the
temperature equilibration and reading phases to
ensure linearity. Precise measurement of the high
absorbance is necessary, demanding good optics
and a flat meniscus. Because ribose-5-phosphate is
converted to xylulose-5-phosphate by endogenous
pentose phosphate isomerase and pentose phos-
phate epimerase, which are present in erythrocytes
in nonlimiting amounts, it is not necessary to add
xylulose-5-phosphate to perform the assay.25,26 The
assay does not require a calibrant. Quality control
specimens can be prepared from bulk samples from
single donors and stored at –70 °C; the between-
assay coefficient of variation (SD*100/mean) of
controls in the “adequate status” range is typically
3–5 percent.
Data analysis and presentation. ETK activity
is expressed in terms of the rate of decrease of
absorbance at 340 nm, corrected for any changes
in the reagent blank. But, as ETK activity does not
directly indicate the portion of the enzyme actu-
ally bound to ThDP, the enzyme activity should be
measured in the presence and absence of exoge-
nous ThDP. The ratio of activities under these
conditions, that is, the ETK activation coefficient
(ETKAC = ETK activity with added ThDP/baseline
ETK activity) should be reported. This is sometimes
expressed as the percentage activation . Thiamine-
adequate subjects typically have ETKAC values
1.15 (  15%), indicating that they have >85%
of ETK bound to ThDP. Subjects with ETKAC val-
ues<1.15 (< 15%) are considered to be at low risk
of clinical thiamine deficiency; those with ETKAC
values 1.15–1.25 ( 15–25%) or >1.25 ( > 25%)
are considered to be at moderate and high risks,
respectively.27 Symptoms of beriberi, the primary
disease of thiamine deficiency, have generally been
associated with ETKAC values >1.4 ( > 40%).
Alternatively, basal ETK activity per unit mass of
hemoglobin may be reported.
Challenges and limitations of ETKAC assessment.
Preanalytical:
1. As freezing causes erythrocyte lysis, ery-
throcyte washing must be completed before
freezing.
2. Fresh-frozen specimens must be used; freeze
thaw cycles can diminish the transketolase
activity. Thus,multiple aliquots shouldbepre-
pared and stored in the event that a sample
needs to be reanalyzed.
Analytical:
1. There is a requirement for identical temper-
ature for each enzyme assay procedure; if
the assay is performed in a microplate, this
requires a microplate reader-incubator that
achieves equal temperature in all wells.
Ribose-5-PO4 + Xylulose-5-PO4 Sedoheptulose-7-PO4 + D-Glyceraldehyde-3-PO4
Transketolase
Triose phosphate isomerase
Glycerol dehydrogenase
Dihydroxyacetone-PO4
Glycerol-3-PO4 + NAD+
D-Glyceraldehyde-3-PO4
Dihydroxyacetone-PO4 + NADH
Figure 3. The sequential reactions involved in the erythrocyte transketolase (ETK) assay.
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Table 3. Analytical requirements for thiamine biomarkers
ThDP ETKAC
Assay type Direct measurement Indirect/functional assay
Analytical instrument HPLC or LC–MS/MS UV spectrophotometer
Specimen type Whole blood or washed erythrocytes Washed erythrocytes
Collection tube Heparin or EDTA Heparin or EDTA
Sample processing 3× saline wash to purify erythrocytes or
hemolyzed whole blood
3× saline wash to purify erythrocytes
Minimum volume For HPLC: 300 L
For LC–MS/MS: 150 L
30 L
Storage Room temperature for a few hours, store at
–20 °C for a few months, –70 °C for several
months/years
Room temperature for a few hours, store at
–20 °C for a few weeks, –70 °C for several
months/years
Shipping Dry ice Dry ice
ThDP, thiamine diphosphate; ETKAC, erythrocyte transketolase activation coefficient; HPLC, high-performance liquid chromatog-
raphy; LC–MS/MS, liquid chromatography coupled to tandem mass spectrometry; EDTA, ethylenediaminetetraacetic acid.
2. There is no gold-standard assay against which
to standardize the ETKAC assay.
3. The assay can be difficult to standardize, and
interassay precision can be poor unless careful
analytical procedures are followed.
Interpretational:
1. ETK activity can be influenced by factors
other than ThDP concentration, such as age,
genetics, and variability in binding of the
apoenzyme.17
A summary of the analytical requirements for the
ThDP and ETK assays can be found in Table 3.
The relationship between ETKAC and whole
blood or erythrocyte ThDP concentrations
Threshold ETKAC values indicative of thiamine
deficiency or adequacy are based largely on results
of dated studies in animal models. No cutoff values
are available for erythrocyte or whole blood ThDP
concentrations, which to date have been studied
predominantly in thiamine-adequate adults from
high-income countries.16 Limited data are avail-
able from two different clinical series of Euro-
pean patients with either chronic alcoholism28 or
other illnesses17 to compare blood ThDP levels and
ETKAC values in the same individuals. For exam-
ple, one study of 63 medical and surgical patients
at risk of thiamine deficiency (e.g., with chronic
renal failure) found that the inflection point in
the ETKAC−ThDP curve occurred at an ETKAC
value of approximately 1.25 (i.e., 25% activation
overbaseline),whichcorresponded toabloodThDP
Figure 4. Comparison of the erythrocyte ThDP assay and
ETKAC values from medical and surgical patients who were
determined to be at risk of thiamine deficiency (from Talwar
et al.17). ThDP, thiamine diphosphate; ETKAC, erythrocyte
transketolase activation coefficient.
concentrationof 280ng/g hemoglobin (Fig. 4). Sim-
ilar results were reported from the study of patients
with chronic alcoholism.28 However, it is not certain
if the same results would occur in populations with
endemic thiamine deficiency.
Therefore, there is a need to generate cutoff
values for erythrocyte or whole blood ThDP
concentrations indicative of both clinical thiamine
deficiency and adequacy in at-risk populations,
such as pediatric populations—who are espe-
cially vulnerable—in countries where beriberi is
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reported. Such studies should assess the relation-
ships of ETKAC values and whole blood or eThDP
concentrations and compare both to measures of
thiamine intake and clinical parameters of health.
Point-of-care diagnostics for rapid
assessment of thiamine status
The assessment of biomarkers of thiamine status
is not widely practiced, particularly in LMIC. It
appears that only one laboratory, in Cambridge,
UK, currently determines ETKAC, and that only
a few laboratories currently measure ThDP and/or
ThMP in erythrocytes. The cold chain required to
transport the samples to laboratories adds costs and
challenges to assessment of thiamine status. As clin-
ical thiamine deficiency may present suddenly and
be rapidly fatal, especially in infants, clinicians are
advised to treat suspected beriberi patients empiri-
callywith thiamine.A rapid, positive response to thi-
amine is conventionally interpreted as confirmation
of deficient thiamine status. A rapid test of thiamine
status that avoids the need for a cold chain would be
useful both in clinical practice and for nutritional
surveillance.
Point-of-care (PoC) diagnostics have recently
emerged as an analytical alternative for remote set-
tings. Microfluidic devices are attractive candidates
for use with PoC applications for diagnostics.29,30
Alternatively, a PoC device could detect ThDP
(or chemical analogs) based on electrochemical
properties. Portable electrochemical analyzers
have been recently developed by the Plaxco,31
Whitesides,32 and Wheeler laboratories.33 New
methods are also being developed using a modified
thiamine binding protein, which recognizes ThDP
and ThMP, produced in Escherichia coli. Based on
the initial report, this fluorescence-based assay has
a lower limit of detection of 0.5 nM, and range
between 1 and 370 nM, which puts it well within the
physiological concentrations of thiamine in human
blood and provides a relatively rapid (30min) and
high throughput method for thiamine analysis.34
Dried blood spot (DBS) samples, which are
already used worldwide for newborn screening,
coupled with a microfluidic paper-based analytical
device (PAD) could potentially make population
assessment easier, more cost-effective, and faster
for the detection of thiamine deficiency. Shih
et al. have demonstrated DBS analysis by digital
microfluidics.35 Two companies, Diagnostics For
All (DfA) and MC10, have also developed a PAD
for the detection of vitamin A.36 The device has
been used to detect vitaminA colorimetrically using
a competitive assay for retinol-binding protein
at a cost of $1 per test (including the integrated
reader). Developing DBS-based techniques to
analyze thiamine content could potentially simplify
the cold-chain and make assessment more readily
available. The above-mentioned devices, as well
as a myriad of low-cost PoC solutions presented
by other groups and organizations, are still under
development. Extensive field testing and evaluation
against gold standards will be required before
applying these devises for routine use in thiamine
status assessment.
Thiamine deficiency and its consequences
Risk factors for thiamine deficiency
Thiamine deficiency is rare in healthy individuals in
food-secure settings, where access to thiamine-rich
foods ensures adequate intakes.9 Regions where
diets are monotonous and the primary sources of
energy are starchy, low-thiamine staples, such as
polished rice or cassava, are likely to be at high risk
of thiamine deficiency.37–39 Regular consumption
of foods containing thiamine antagonists, such
as betel nut or tea leaves, and thiaminases in
foods such as raw fish and African silkworm
larvae, have also been implicated as precipitants
of thiamine deficiency.9,12,40 Some bacteria (e.g.,
Clostridium botulinum) are also capable of pro-
ducing thiaminases.41 Conditions that lead to food
insecurity, including drought, conflict, displace-
ment due to war, famine, or natural disaster, as
well as severe acute malnutrition (SAM), raise the
risk of deficiency.42–45 Abnormal gut microbiota,
as occurs in SAM, may also play a role in reduced
thiamine uptake.46,47
Infants are particularly vulnerable to the effects
of thiamine deficiency in the first months of
life, and exclusively breastfed infants of thiamine-
deficient mothers are at highest risk.16,48 Thi-
amine deficiency is also frequently observed in
patients who are critically ill or in intensive
care because of increased demand for thiamine
(hypermetabolism).49–54 In clinical practice, asso-
ciated comorbidities and other risk factors, such
as SAM with fever and shock and use of
dextrose-based intravenous fluid, further increase
the risk of thiamine deficiency.42 Most other cases of
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thiamine deficiency occur among alcoholics,28 post-
operative bariatric surgery patients,55 or patients
with advanced HIV infection/AIDS,56,57 who tend
to have low thiamine intakes or absorption and
impaired thiamine utilization.
Children with SAM often have multiple risk fac-
tors for thiamine deficiency. Upon admission to a
hospital, these patients often receive several days
of a low-protein 75 kcal/100 mL refeeding milk
formula (F75), which provides a possibly insuffi-
cient amount of thiamine (0.5–1.7 mg/day depend-
ing on the total daily F75 intake). Several experts
have recently recommended increasing the thiamine
content of this formula to align with therapeutic
amounts.58
Diseases associated with thiamine deficiency
Overt thiamine deficiency syndromes represent a
spectrum of clinical presentations that have been
historically divided into two categories based on
symptomology: (1) beriberi, which can be “wet”
if it predominantly affects the cardiovascular sys-
tem and is accompanied by edema, or “dry” if
it predominantly affects the peripheral nervous
system; and (2) Wernicke’s encephalopathy or
Wernicke-Korsakoff syndrome.5,59 Beriberi affects
the cardiovascular system (e.g., acute cardiologic
form), nervous system (e.g., pseudo meningitic
form), or both; whereas Wernicke’s encephalopa-
thy primarily presents with neurological signs
(e.g., encephalopathy and peripheral neuropathy
forms),39 as described inmoredetail in Figure 5. The
most important pediatric presentation—usually
referred to as infantile beriberi—has a wide range
of nonspecific clinical features and organ involve-
ment, including central nervous system abnormal-
ities, mainly characterized by heart failure. Infan-
tile beriberi sometimes presents in the context of
an acute infectious illness, further complicating
the diagnosis.39,42 The consultation group suggested
adopting the umbrella term thiamine deficiency dis-
orders (TDDs) to describe the spectrum of overlap-
ping clinical presentations attributable to thiamine
deficiency across the life course. However, the term
beriberi (without wet/dry subtype disaggregation)
remains commonly used in clinical pediatrics, so it
is retained here to refer generally to TDDpresenting
in infancy.
TDDs primarily occur in low-income countries
as a result of low dietary thiamine intake. The risk
of TDD is highest in the first year of life, espe-
cially during the period of exclusive breastfeeding,
as mothers in regions where the disease is preva-
lent are thiamine deficient and thiamine content of
breastmilk is related to maternal thiamine status.48
Infantile beriberi is rare in the first 2 months of
life, as thiamine levels are higher in newborns,
and then falls rapidly in the third month of life,
likely due to changes in metabolic activity.60 It has
been recognized in areas of Central and Southeast
Asia,61 especially in Myanmar,44,62 Laos,63–65 and
Cambodia;13,66 but, TDDs have also been observed
in West Africa,67 Angola,45 Mayotte Island,68
Kiribati,69 Cuba,70 and parts of the Caribbean, and
may go unrecognized in other settings.221
Infantile beriberi in children younger than 4
months of age typically presents first with nonspe-
cific signs, including irritability, refusal to breast-
feed, tachycardia and tachypnea, vomiting and
incessant crying that is often described as “loud” or
“piercing” and in some cases evolves into a “silent
cry,” or aphonia.39 As the disease progresses, signs
and symptoms of congestive heart failure begin to
appear, such as tachypnea, tachycardia, pulmonary
edema, hepatomegaly, and, sometimes, cyanosis; at
this point, deterioration of the clinical condition
is often rapid. As beriberi may be misdiagnosed as
a viral infection, pneumonia, typhus, or malaria,
beriberi patients may die before the correct diag-
nosis of thiamine deficiency is made.42,44,71 Prompt
recognition of beriberi and immediate administra-
tion of thiamine produces rapid recovery. Within
hours, even infants with advanced beriberi return to
breastfeeding and, within days, their cardiac func-
tion returns to normal. Shoshin beriberi is a ful-
minant form of wet beriberi (acute cardiogenic
shock with lactic acidosis multiorgan failure and no
edema) and can easily mimic sepsis.72–76 Because
of uncertainties regarding the diagnostic criteria of
TDDs, it may only be possible to diagnosis beriberi
after a patient demonstrates significant improve-
ment following treatment with thiamine.
Beriberi in older infants and childrenmay present
with predominant neurological symptoms, includ-
ing loss of appetite, nystagmus, ophthalmoplegia,
bulging fontanelle, and loss of consciousness.59,77–79
In areas with low awareness of thiamine deficiency,
symptoms are easily mistaken for meningitis. In
some cases, these signs may overlap with cardiac
symptoms of beriberi. Older children, adolescents,
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• Peak prevalence in
breastfed babies of
1–3 months of age
• Colic
• Restlessness
• Anorexia
• Vomiting 
• Edema
• Cyanosis and 
breathlessness
with signs of heart 
failure leading 
to death
• Pernicious form or
Shoshin Beriberi
• Sudden cardiogenic
shock
• Peak prevalence in
4- to 6-month-old 
infants
• Initially hoarse cry 
until no sound is 
produced while 
crying
• Restlessness
• Edema
• Breathlessness 
and death
• Peak prevalence in 
7- to 9-month-old
infants
• Nystagmus 
(involuntary 
eye movement)
• Muscle twitching
• Bulging fontanelle
• Convulsions 
• Unconsciousness
• Generally older 
children or adults 
but also seen 
in infants
• Psychomotor 
slowing or apathy
• Nystagmus or 
opthalmoplegia
• Ataxia
• Impaired
consciousness
• Eventually coma 
and death
• Older children
or adults
• Pain
• Tingling or loss of 
sensation in hands 
and feet (peripheral 
neuropathy)
• Muscle wasting 
with loss of function 
or paralysis of the 
lower extremities
• Loss of ankle and 
knee reflexes
• Cranial nerve 
impairment
Acute Cardiologic
Form Aphonic Form
Pseudo Meningitic
Form Encephalopathy
Peripheral
Neuropathies
Figure 5. Clinical spectrum of thiamine deficiency disorders. Adapted from the WHO, 1999.39
and adults with TDDmay present only with periph-
eral neuropathy—tingling or loss of sensation in
the feet and hands, pain, and abnormal tendon
reflexes—or with more severe signs of peripheral
nervous system involvement, such as paralysis or
sensory deficits.45,80
Wernicke’s encephalopathy, the most common
form of thiamine deficiency in adults and older
children, is characterized by a triad of signs and
symptoms: abnormal eye movement, gait ataxia,
and cognitive impairment. In younger children,
though, the triad may not include ataxia.81,82 The
most severe form ofWernicke’s encephalopathy can
include a condition called Korsakoff ’s psychosis, in
which patients are amnesiac, profoundly confused,
and display confabulation with little or no working
memory.83 This condition is more common in
individuals with hereditary anomalies of transketo-
lase in which its binding to ThDP is weak. In higher
income countries, Wernicke’s encephalopathy is
most common in alcoholics, as chronic alcoholism
impairs both intestinal thiamine absorption and
increases thiamine requirements for metabolism.
Wernicke’s encephalopathy can also occur in
HIV-infected patients, pregnant women suffering
from hyperemesis gravidarum, and postoperative
bariatric patients.84,85 If thiamine deficiency is
corrected before the development of significant
brain damage, the neurological symptoms may
be completely reversible. However, if thiamine
deficiency persists, it can result in permanent
brain damage.83,86 As Wernicke’s encephalopathy
in adults—especially in the nonalcoholic or chroni-
cally ill population—is less often fatal than infantile
beriberi, it will not be extensively discussed here;
readers interested in Wernicke’s encephalopathy
are referred to several excellent reviews of the
disease.59,81,83,85,86
Some children with beriberi and adults with
Wernicke’s encephalopathy display similar brain
changes on magnetic resonance imaging, specifi-
cally, bilateral, symmetric hyperintensity signals in
the mammillary bodies, thalamic, and periaque-
ductal areas; however, pediatric brain neuroimaging
may also show lesions in the basal ganglia and
the frontal lobes. In a recent study of infants
with thiamine deficiency encephalopathies, cranial
ultrasound revealed hyperechoic lesions of the basal
ganglia.73,77,79,87
AdditionalputativeTDDsfound inAfrica. Trop-
ical ataxic neuropathy (TAN) is characterized by
sensory polyneuropathy, gait ataxia, bilateral optic
atrophy, and deafness. TAN is endemic in Nigeria,
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Ghana, and other West African nations where cas-
sava root is aprimary sourceof energy.88,89 The etiol-
ogy of TAN is not well understood and was thought
to be related to the consumption of cyanogenic gly-
cosides naturally present in cassava. However, this
hypothesis has not been confirmed experimentally.
On the other hand, in a placebo-controlled trial,
TAN patients have shown significant improvements
with thiamine administration, suggesting that the
condition may be due to thiamine deficiency.89
Epidemic spastic paraparesis, also known as
konzo, is an upper motor neuron disease associ-
ated with conditions of food shortage (e.g., famine
and drought) in Central and East Africa, where it
has been found to be a leading cause of disability in
young children.90,91 Like TAN, konzo has been asso-
ciated with consumption of cyanogenic glycosides
from under-processed cassava. As konzo patients
display some overlapping symptoms of dry beriberi,
thiamine deficiency has been suspected to play some
role in this disease. However, there are as yet no clear
data implicating thiamine deficiency in the patho-
genesis of konzo.91
The Nigerian rainy season also produces epi-
demics of seasonal ataxia associated with consump-
tion of the roasted larvae of the African silk worm,
Anaphe venata, which contains thiaminases.92
Patients initially present with nonspecific signs such
as nausea, vomiting, and dizziness. They rapidly
develop nystagmus, tremor, dysarthria, ataxia, con-
fusion, and coma. Early thiamine administration
can reverse symptoms within 72 hours. Health
education campaigns focused on raising awareness
among hospital workers, hospitalized patients, and
their relatives have been effective in reducing the
prevalence of seasonal ataxia.40,93
Variable presentations
Asmentionedabove, thiamine is a cofactorof several
key cellular enzyme complexes found in mitochon-
dria; thiamine deficiency, therefore, may be consid-
ered to be an acquiredmitochondrial disease, which
explains the multiple organ involvement, includ-
ing the nervous and cardiac systems.42 Owing to
the highly variable clinical presentations of TDD
(Fig. 5) and the lack of consensus on clinical case
definitions or biomarkers, these conditions are often
misdiagnosed, possibly leading to gross underesti-
mation of the prevalence of TDDs in many parts
of the world. It is not clear why some thiamine-
deficient children present with only cardiac signs,
while others present only with neurological signs.
However, it is suspected that overall nutritional sta-
tus and thepresenceor absenceof comorbidities and
multiple micronutrient deficiencies may contribute
to the variable clinical presentations of thiamine
deficiency.
Long-term and subclinical consequences
As thiamine administration rapidly alleviates signs
and symptoms of deficiency, patients with TDD
can apparently make a full physical recovery if
treated early. It was long believed that subclini-
cal thiamine deficiency had no long-term seque-
lae.However, persistent cognitive andmotor deficits
are now being recognized among children who
experienced infantile thiamine deficiency. Longi-
tudinal studies of Israeli children who survived a
2003 outbreak of thiamine deficiency after con-
suming an infant formula in which thiamine
was erroneously omitted have shown long-term
medical, neurodevelopmental, and gross motor
impairments.94,95
The most severely affected survivors demon-
strated marked intellectual disabilities, seizures,
motor disabilities, microcephaly, auditory dys-
function, and complete heart block.94 Not all
infants who received thiamine-deficient formula
were initially symptomatic; but even those who
initially appeared unaffected subsequently dis-
played delayed language acquisition, persistent lexi-
cal and syntactical language impairments,96 gross
motor delays,95 poor fine motor and coordi-
nation skills,97 dyslexia, and learning disabilities
(unpublished data). It is assumed that these effects
are the result of neuronal insult during a crit-
ical period in brain development. Considering
the Israeli experience, one could hypothesize that
it is possible that negative cognitive and devel-
opmental outcomes resulting from early and/or
lifelong subclinical thiamine deficiency may also
occur in regions where dietary thiamine intake is
low.
More research is needed to understand the long-
term developmental effects of subclinical thiamine
deficiency and to identify the factors that may trig-
ger overt clinical disease in both infants and adults.
Studies of Cambodian children have shown that
blood ThDP levels of beriberi patients are often
the same as their asymptomatic peers, which has
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led experts to believe that asymptomatic or sub-
clinical thiamine deficiency may quickly shift to
acute beriberi in the presence of other physiological
stressors (e.g., acute infection, diarrhea, and para-
sitic infection).13 Additionally, there have been no
long-term intervention trials examining the impacts
of maternal/infant thiamine supplementation on
developmental outcomes—a critical research gap
that the consultation group suggests should be
urgently filled.
Cohorts of children treated for thiamine defi-
ciency should also be followed in longitudinal
prospective studies and evaluated for possible
short- and long-term sequelae of thiamine defi-
ciency with serial neuropsychological testing and
neurophysiological tests, such as nerve conduction
studies, electroencephalography, and visual evoked
potential testing. To facilitate neuropsychological
studies in resource-poor settings, simple, neurocog-
nitive and neurodevelopmental-testing instruments
need to be developed and validated for use in local
communities.
Despite a lack of consensus on the case defi-
nition of thiamine deficiency, clinical experiences
have led experts to believe that many individuals in
populations where thiamine intake is low teeter on
the brink of clinical deficiency, and can be quickly
pushed into overt deficiency by factors such as acute
infections or other illnesses. The case studies of
Israeli children exposed to a thiamine-deficient for-
mula diet are among the only studies of beriberi
in children who were otherwise well nourished.98
The long-term follow-up of that cohort will be
important for understanding the delayed effects of
isolated thiamine insufficiency on neurobehavioral
development.
A case definition for TDDs
Although TDDs are well documented in case stud-
ies, epidemiological studies linking thiamine defi-
ciency to specific clinical scenarios are rare.Thismay
be attributable to the heterogeneities in disease pre-
sentation and difficulty of assessing thiamine status.
The consultation group agreed that developing
case definitions of the various TDDs may reduce
some of the confusion surrounding diagnosis, and
that this endeavor is a worthwhile subject for future
research. Prospective cohort studies of childrenwith
clinically suspected beriberi would be valuable in
identifying which combinations of clinical features
are most predictive of confirmed thiamine defi-
ciency. Such studies may enable the development of
consensus case definitions for thiamine deficiency
that are based on presenting clinical findings with-
out requiring biochemical testing and could be used
effectively by researchers and clinicians.
Developing a case definition. Criteria for enrol-
ment of sick infants and children in a cohort study
should be broad and inclusive to account for the
wide spectrum of signs and symptoms of beriberi
reported by clinicians and healthcare staff in areas
where TDDs are prevalent (Fig. 6). Within the
cohort, a subset of children may be subsequently
identified as having a confirmed TDD. The accepted
standard for diagnosing TDD in the absence of bio-
chemical analysis is “clinical response to thiamine”
(50−100 mg dose).74 A case definition would be
based on the combination of presenting clinical fea-
tures that are most predictive of clinical response
to thiamine. As the research and clinical surveil-
lance evidence base expands, TDD definitions may
be refined, but should still serve as a guide to indicate
when empirical treatment with thiamine should be
encouraged, particularly as there is no known risk
to treatment and the cost of treatment is relatively
low.
The initially proposed broad definition can
be used to identify possible cases of thiamine
deficiency, but confirmation of these conditions
requires different protocols, including response to
thiamine supplementation and biochemical indica-
tors of thiamine status.
The following algorithm for thiamine therapeutic
challenge includes the association of well-identified
risk factors and clinical conditions. Clinical mani-
festations in the presence of risk factors (Fig. 7) can
be used to define the condition classified as “most
likely TDD” when there is an expectation of signif-
icant clinical improvement within 24 h of thiamine
therapeutic challenge or as “probable TDD” if
significant clinical improvement is observed within
72 h of a thiamine therapeutic challenge.
Prevalence of thiamine deficiency and
burden of TDDs
Based on existing biomarker studies and case
reports of thiamine-responsive conditions, along
with information on the use of polished rice or cas-
sava as primary staples in the diets of many poor
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• Sudden heart failure between 1 and 6 months
• Incessant cry, hoarseness, followed by loss of voice
• Cyanosis and difficulty breathing 
• Significant liver enlargement
• Bulging fontanelle
• Nystagmus
• Muscle twitching
• Loss of consciousness
• Fits (without fever)
• Difficulty walking (ataxia)
• Abnormal eye movements
• Confusion, behavior change
• Impaired consciousness, coma
• Bilateral tingling and numbness in limbs
• Lethargy, apathy
• Tachycardia with warm extremities
• Signs of B-vitamin deficiency (e.g., angular stomatitis)
• Reduced suckling or refusing to feed 
for at least 48 h
• Repetitive vomiting
• Constipation
• Tachycardia with warm extremities 
without fever (early sign)
Case definitions: at least three major manifestations OR at least two major + two minor manifes-
tations AND response to thiamine within 24 h (very likely TDD) OR within 72 h (probable TDD)
Major Manifestations
In
fa
nt
Ch
ild
 o
r a
du
lt
Minor Manifestations
Figure 6. An example of a proposed case definition of thiamine deficiency disorder (TDD).
households in LMIC, risk of thiamine deficiency
is thought to be of potential public health impor-
tance in many communities in Southeast Asia (e.g.,
Cambodia, Laos, and Myanmar), South Asia
(e.g., Nepal and Northern India), and West
Africa.63,66,75,99
Experts agree that discrepancies in data pro-
duced by different laboratories and assay methods
complicate assessment of the global prevalence of
thiamine deficiency; and the dearth of population-
level biomarker data currently undermines efforts
to determine the global and regional burden of
disease. Increasing the number of countries that
conduct thiamine status surveys using a biomarker
such as ThDP or ETKAC would substantially
improve global prevalence estimates. In regions
such as sub-Saharan Africa, where there may be an
unrecognized problem, these status surveys could
be especially important: if a problem is identified in
one country, then the surrounding areas may also
have thiamine deficiency.
Cambodia
Suboptimal thiamine status and TDDs have been
recently documented in Cambodia.16 Verbal
autopsy review suggests that approximately half
of children dying after the neonatal weeks but
during the first 6 months of life might have had
beriberi.54 In 2012, Coats et al. published the
results of a case–control study in which 27 infants
presenting with clinical symptoms of beriberi (and
their mothers) were compared with 27 infants and
mothers without beriberi who also presented at
a health clinic in Mesang District, Prey Veng, and
20 healthy American control dyads.13 Interestingly,
there was no significant difference in the whole
blood ThDP of Cambodian mothers and infants
with or without beriberi.13 However, both sets of
Cambodian mothers and infants had significantly
lower ThDP than the Americans.13 Other cases of
infantile beriberi have been reported in this same
clinic in Mesang District in Prey Veng,66 as well as
at a clinic in Siem Reap province.71
In 2013, Whitfield and colleagues conducted
an exploratory cross-sectional study to assess the
thiamine status among women of reproductive
age in rural and urban Cambodia, compared with
women in Canada. Not surprisingly, they found
significantly lower eThDP among nonpregnant,
nonlactating women of reproductive age in both
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Established high prevalence of
thiamine deficiency in the population
AND/OR
TDD suspicion
(case definition)
Acute life-threatening illness
(cardiac, respiratory, 
neurological)
Humanitarian settings or labile 
food security (e.g., conflicts or 
disasters, refugee/IDP)
Severe acute malnutrition
Monotonous diet relying heavily
on polished rice, refined flour,
or cassava
Thiaminase consumption
Clinical guidelines to determine use of thiamine administration in probable cases of TDD in LMIC
+ =
One or more risk factors
Thiamine
therapeutic
challenge
Clinical presentation
Figure 7. Clinical guidelines for empirical treatment of suspected thiamine deficiency disorders (TDDs). LMIC, low- andmiddle-
income countries; IDP, internally displaced person; TDD, thiamine deficiency disorder.
rural PreyVeng (mean± SD, 149± 36 nmol/L RBC;
n= 121) and urban PhnomPenh (156± 32 nmol/L
RBC; n = 117), compared with women from
Vancouver, Canada (179 ± 37 nmol/L RBC; n = 47;
P < 0.05).37,100 Although statistically significant,
the authors note the relatively small absolute dif-
ference between women in Cambodia and Canada,
which may be attributed to the small sample size
and/or convenience sample of Vancouver women,
the majority of whom were young university
students.
The first-ever Cambodian National Micronu-
trient Survey was conducted in conjunction with
the 2014 Cambodian Demographic and Health
Survey.101 This was a nationally representative sur-
vey of adults 15−49 years of age and their chil-
dren (6–59months) from 24Cambodian provinces;
eThDP was measured in 719 women and 761 chil-
dren. The women’s mean (95% CI) eThDP was
150 nmol/L RBC (146−153); the children’s was
174 nmol/L RBC (171−179). As noted above, there
are no widely accepted interpretative criteria for
the classification of thiamine deficiency based on
eThDP; nearly all of the cutoffs that have been
used previously were derived from healthy popula-
tions, and most were calculated with fewer than the
best practice of a minimum of 120 individuals.102
Two of the most extreme cutoffs from the liter-
ature define thiamine deficiency as <118.5 and
<180 nmol/L RBC. The cutoff of <118.5 nmol/L
RBC is the 95th percentile reference range among
healthy black South African adults103 and was used
in Bailey et al.;104<180 nmol/L RBC is the 25th per-
centile of 103 healthy, asymptomatic adult employ-
ees ofUniversity “La Sapienza”Hospital inRome.105
With a cutoff of eThDP<120 nmol/L RBC,104,106,107
27% of mothers and 15% of children in the Cam-
bodian survey would be considered thiamine defi-
cient; however, prevalence rates of deficiency were
as high as 78% for mothers and 58% for children
using the higher cutoff of<180 nmol/L RBC, high-
lighting the difficulties with establishing prevalence
rates in the absence of clear cutoffs for thiamine
deficiency.105
Finally, Cambodians have been responsive to
increased thiamine intakes, both through diet, as
from randomized controlled trials byWhitfield et al.
of thiamine-fortified fish sauce showing increases
in eThDP100,108 and breastmilk thiamine,100 and
through thiamine supplementation, as shown in
a recent pharmacokinetics study by Coats et al.109
Improvements to thiamine status upon supple-
mentation are indicative of initial suboptimal
status, as similar increases have not been observed
among thiamine-replete individuals. In part, this
stems from the differential thiamine absorption
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depending on concentration: below 1 mol/L,
thiamine is transported through an active, carrier-
mediated, sodium-dependent mechanism, whereas
at higher concentrations thiamine is absorbed
via passive diffusion.110 An experimental thi-
amine supplementation study among six healthy,
thiamine-replete Canadian males in the 1960s
found 21% absorption of a 2.5-mg thiamine dose,
but decreased absorption of 9% and 4% at doses
of 5 and 20 mg, respectively.111 Also, little thiamine
is retained among thiamine-replete individuals;112
for example, Australian researchers found rapid
urinary excretion of thiamine among six volunteers
(22−43 years; n = 3 men and 3 women) who
consumed an 11-mg dose of thiamine.110–112 In
the study of thiamine-fortified fish sauce, there
was a statistically significant response between
baseline and endline regardless of baseline thiamine
status, except for the women who received the most
heavily fortified fish sauce (where there was only a
significant increase from baseline to endline among
those women in the lowest tertile at baseline).108
Laos
There are several recent case reports of beriberi and
suboptimal thiamine status among infants in Laos.
A survey of 22 villages in northern Laos (various
ethnic groups) reported a high infant (<6 months
of age) mortality rate of 50 deaths among 468 live
births.63 Of these 50 infant deaths, 36 occurred
when infants were 1−3 months of age, and 17 were
suspected to be caused by infantile beriberi.63 In
the capital city of Vientiane, 13% of a cohort of
778 sick infants <1 year were found to have bio-
chemical evidence of thiamine deficiency (defined
as basal ETK activity<0.59, without clinical signs of
beriberi).12
Another study of hospital records in Laos offered
retrospective data on beriberi cases. Based on
reports from51hospitals (including central, provin-
cial, and district hospitals), about 60 infants under
12 months of age were treated with thiamine
for beriberi each month, but biochemical mea-
sures were unavailable. In the catchment areas
of these hospitals, there are an estimated 71,696
infants under 12 months old. Adult beriberi cases
were much lower—an average of 20 men and
16 women were treated for thiamine deficiency per
month. Therewas no seasonality associatedwith the
caseload. In population centers like Luang Prabang,
where health workers are reportedly more aware of
the symptoms of beriberi, infant prevalence is high-
est at an estimated 2.5 per 1000 infants (Lao PDR
Ministry of Health, unpublished data).
Myanmar
As described above, beriberi is the second lead-
ing cause of postneonatal death of children 29 to
365 days old in Myanmar. On a national level, this
equates to 17% of infant (29 to 365 days old) deaths,
but is more common in rural areas.113 Currently,
Myanmar is combatting thiamine deficiency by pro-
viding10mg/day thiamine supplements topregnant
and lactating women up to 3 months postpartum.
Kashmir (India)
A number of reports of infantile beriberi have
emerged from the northern region of India, where
the diet consists largely of polished, unfortified
rice.75,77,79,114 Cases all occurred in infants who
were exclusively breastfed, and the majority of
mothers followed a customary dietary restriction.
Postpartum food avoidances in this region lead
to especially thiamine-deficient diets consisting
of polished rice and chicken soup.74 Nearly, 100
infants documented in these papers had either
pulmonary hypertension or encephalopathy and
nearly all responded to thiamine at the Government
Medical College in Srinagar.
Outbreaks and individual case reports
Aside from the areas described above where
thiamine deficiency is endemic, there have been a
number of outbreaks reported in specific subpop-
ulations within LMIC. Table 4 presents a list of the
published outbreaks of TDDs in LMIC since 1980.
As is the case in endemic areas, most of these cases
of thiamine deficiency were caused by a limited diet
that was high in polished rice. These recent out-
breaks from LMIC suggest that thiamine deficiency
can occur anywhere and under a number of cir-
cumstances. They also highlight the need for greater
awareness of the clinical presentation of TDD in
order to promptly diagnose and treat thiamine
deficiency and prevent mortality associated with it.
There have also been clinical case reports of sub-
optimal thiamine status in various high-income
countries where beriberi was previously thought to
be nonexistent or eradicated. Such reports include,
for instance, a 24-year-old Japanese man present-
ing with beriberi after subsisting on rice balls for
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Table 4. Publishedoutbreaksof thiaminedeficiency (at least 15people affected) since1980 in low-andmiddle-income
countries where deficiency is not known to be endemic
Continent Country Year
Population or
location Number of cases Deaths Age of cases Notes Refs.
Asia and Pacific
Bhutan 2015 Female
boarding
school
students
17 (all females) 0 9−18 years Thiamine
deficiency
increased later
in the school
year
174,175
Papua New
Guinea
2009 Boarding
school
students in
Southern
region
6 severe
deficiency, 24
marginal
deficiency;
63% females
0 14−22 years 176
Thailand 1994−1995 Rural
Northeast
31 thiamine
deficient
(thiamine
effect>20%);
34 thiamine
deficient 6
months later
0 6−12 years No association
with parasitic
infection
177
Thailand 2005 Male fishermen
in Maha
Chai
15 (12 probable,
3 confirmed)
2 20−40 years 2 months on a
diet of fish
and polished
rice and 18
months at sea
178
Thailand 2012−2013 Factory
workers in
Chacho-
engsao
17 (suspected) 3 (all
males)
20−30 years Likely due to low
thiamine and
heavy physical
activity
179
Taiwan 1999 Chinese
immigrants
in a
detention
center
34 probable and
70 possible
cases out of
176 surveyed
2 (all
males)
22−40 years Average
thiamine
intake among
the 15
hospitalized
patients was
0.49±0.1mg/day
180
Kiribati 2012−2015 Adult men,
pregnant
and lactating
women, and
infants
34 confirmed (of
72 suspected
cases)
9 <1 to>50
years
Majority of cases
reported from
September
2014–January
2015, but
cases were still
reported in
2017. Diet on
Kuria Island is
mainly
imported
unfortified
white rice
69
Continued
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Table 4. Continued
Continent Country Year
Population or
location Number of cases Deaths Age of cases Notes Ref
Africa
South Africa 1981−1985 Patients
admitted to
King Edward
VII Hospital
in Durban
41 (23 “fairly
certain”
beriberi)
Adult men High
consumption
of Zulu beer
181
Somalia 2009−2010 Male African
Union
soldiers
241 4 29 years
(mean)
Restricted diet 182
Gambia 1990−1991 Urban 38; 27 men and
11 women
4 Men 36
years;
women
35 years
Later half of
rainy season
183
Gambia 1988 North Bank
region
140 (suspected) 22 Adults and
children
Twice the
average
rainfall
67,184
Coˆte d’Ivoire 2002−2003 Abidjan Prison 597 definite
cases; 115
probable cases
(all males)
7 15−73
years (28
mean)
Penal ration
contained 1/5
of recom-
mended
dietary
thiamine
43
Coˆte d’Ivoire 2008 Abidjan prison
(Maca)
205 0 33 years
(mean)
185
“West Africa” 2002 Prisoners 211 25 Adults 186
Guinea 2015 Prisoners 618 1 Adults 187
Mayotte and
Reunion
Islands
(French
Territories)
1997−2005 Mahoran or
Comorian
70 (67%
females) (21
cases in 2004)
27 years
(mean)
Apparently
healthy,
young
nonalcoholic
adults
188
Mayotte Island 2004 Breastfed infants 32 20 3 weeks–6
months
Occurred
between April
and July in
children who
were unsup-
plemented
68
Angola 2002 Chipindo 51 (suspected) 10 4 months–
86 years
(21.3
years
mean)
Extremely
limited diet
due to
conflict; 32
cases were
under 15
years
old––most at
risk
45
Continued
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Table 4. Continued
Continent Country Year
Population or
location Number of cases Deaths Age of cases Notes Ref
Americas
Brazil 2006−2008 Prospective
study of PICU
patients at the
Hospital of
Sa˜o Paulo
57 1.7 years
(mean)
Magnitude of
inflammatory
response was
a risk factor
49
Brazil 2008 Macuxi
Amerindian
communities
in Roramia
87 3 31 years
(1−85
years)
90% of cases had
“normal”
ThDP
189
Brazil 2006−2008 Maranha˜o State 1207 40 (1
female)
20−40
years
Cases were
largely from
May to
August, in
young,
low-income
men
performing
heavy labor
191
French Guiana 2013−2014 Illegal gold
miners
42 (5 females) 1 22−65 years Cases still
reported in
2016
190
Cuba 1992−1993 Pinar del Rio
and Havana
107 0 >15 years 70
Colombia 1991−1993 Marines in the
Naval School
Almirante
Padilla
22 2 20−21 years 192
4 years,76 and a 38-year-old Scottish man on an
extreme weight-loss diet.115 These isolated cases,
where individual dietary or lifestyle habits were
likely responsible for the case presentation, should
not be considered as evidence for instigating a
national public health intervention.
Methods to estimate the risk of thiamine
deficiency in populations lacking information
on thiamine status
The best indicators of risk of thiamine deficiency
in a population are (1) clinical signs of beriberi
that respond to thiamine treatment, and (2) a
high prevalence of the population with biomark-
ers indicative of deficiency. While a definition of
high prevalence currently does not exist, a cutoff of
20% has been used by the World Health Organi-
zation (WHO) for anemia. However, few countries
have produced representative data on the popula-
tion’s thiamine status, and the interpretation of ery-
throcyte or whole blood ThDP remains uncertain
(as discussed above). Several approaches using food
availability or intake data andmonth-specific infant
mortality rates have been proposed to fill the gaps
in population-level indicators of thiamine status.
For the purposes of this technical consultation,
two preliminary analyses were performed to assess
the population risk of thiamine deficiency using
these proxy measures. It should be noted that these
provide a cursory overview of what could be done
in greater detail to identify areas at risk of TDD.
Because elevated ETKAC represents a functional
abnormality due to thiamine deficiency, we suggest
that this is currently the best biochemical evidence
of deficiency. If more than 10% of the population
has an ETKAC >1.2, this should be considered
evidence of an elevated risk of thiamine deficiency
in the population. When more than 20% of the
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population has an ETKAC above this threshold, this
should be considered a public health problem and
a large-scale intervention should be considered.
Once information is available on the whole-
blood or eThDP concentration that corresponds
to elevated ETKAC, ThDP can be used as an
alternative biomarker for population assessment,
using the same prevalence cutoffs to indicate
whether there is a problem of public health
concern.
Food availability and intake data. It is well docu-
mented that diets high in polished, unfortified rice
can lead to low thiamine intake in a population.63
National food balance sheets (FBSs) provide
information on the annual per capita availability
of different food commodities in a given country,
which can be used to estimate the risk of inadequate
intake of a nutrient based on its availability in the
food supply.116 As expected, the results of this anal-
ysis indicate that there is low availability of thiamine
in the food supply of several countries in Southeast
Asia, including Cambodia, Myanmar, and Laos.
Some LMIC elsewhere in Asia also had low thi-
amine availability, including Sri Lanka, Bangladesh,
Mongolia, and Tajikistan. As described previously,
there may be an underappreciated burden of
thiamine deficiency in Africa. FBS data suggest
inadequate availability of thiamine in the national
food supply of Botswana, Somalia, Libya, Guinea
Bissau, and the Gambia. More work is needed in
these countries and others in the African regions
to assess the possible extent of thiamine deficiency.
While there is some co-occurrence with riboflavin
deficiency, it is not well correlated with thiamine
deficiency.
These analyses considered the fact that rice and
wheat fortification programs may be in place in a
given country, as indicated in Figure 8. Countries
highlighted in turquoise are those where the esti-
mated mean thiamine availability is lower than the
RNI for men (1.2 mg/day). Countries shaded in yel-
low have rice or wheat flour fortification programs
in place that include thiamine; but the coverage of
these programs is not known, so their impact on the
population risk of thiamine deficiency is uncertain.
Countries shaded in gray have an estimated mean
thiamine availability above the RNI for men.
In the Americas, only the Dominican Republic,
Haiti, Ecuador, and Uruguay had inadequate thi-
amine availability. However, all of these countries
except Uruguay fortify wheat and/or maize with
thiamine.
Thiamine intake has also been assessed by
micronutrient status surveys that use 24-h recalls
or food frequency questionnaires (FFQs) to esti-
mate intake. Table 5 shows the results of pub-
lished studies of micronutrient intakes, including
thiamine intakes, of pregnant and lactating women
Figure 8. Map depicting countries where the estimated per capita availability of thiamine in the national food supply (as per
food balance sheets) is below the recommended nutrient intake for men of 1.2 mg/day (in turquoise), and countries where rice or
wheat flour fortification is in place to address low thiamine availability (in yellow). Countries where the estimated mean thiamine
availability is greater than or equal to 1.2 mg/day are in gray.
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in LMIC. These studies suggest the need to assess
thiamine status in a number of areas outside of
Southeast Asia, including parts of Africa (e.g., Burk-
ina Faso) and South America (e.g., Colombia and
Peru).
While the risk of inadequate thiamine intake
has been assessed most frequently through the
use of dietary intake surveys and national FBSs,
household consumption and expenditure survey
(HCES) data are now being usedmore frequently to
estimate household-level micronutrient intake.
These surveys provide several advantages in that the
data are collected routinely in many countries; and
the results are easily subdivided by socioeconomic
status and geographical area, both of which can
affect the risk of inadequate thiamine intakes. For
example, India, a large country with a diverse
population, is not identified by FBS data as a coun-
try with thiamine deficiency. However, infantile
beriberi cases have been reported in recent years
in the northern region of Kashmir, where diets
consist largely of polished rice.75,79,114 The ability
to disaggregate dietary data for specific population
subgroups can be useful in assessing the risk for
thiamine deficiency.
Infant mortality data. Month-specific infant
mortality rates may also be used to identify regions
at high risk of widespread thiamine deficiency. As
noted in the 1999 WHO document on thiamine
deficiency, “the typical feature of infantile beriberi
is that instead of infant mortality decreasing after
the first month, it remains high or even increases to
a peak at about the third month.”39 A second peak
in infant mortality may also be observed around the
sixth month. Thus, plotting infant mortality rates
by month of age can provide useful information as
to whether thiamine deficiency may be a problem
in a country.
To assess this in areas with a known problem,
Demographic and Health Survey (DHS) data from
Cambodia were examined, which shows an increase
in infant mortality around 3 months of age and in
some cases at 7 months (Fig. 9).
While the methods described above can provide
rough approximations of thiamine intake or the
presence of TDD, more data are needed to quantify
the prevalence and severity of thiamine deficiency.
This would ideally be done through biomarker sur-
veys of thiamine status in representative samples of
the population and active surveillance for cases of
beriberi.
Thiamine status assessment decision tree
Introduction and purpose of the decision tree
Suboptimal thiamine status has been called the “for-
gotten disease of Asia,”12 as reports of TDDs in the
region are common despite the known etiology and
relatively straightforward approaches to prevention
and treatment.117 There is current evidence of sub-
optimal thiamine intake or status in Southeast Asia,
notably in Cambodia,13,37,66,71,100,108 Laos,12,63,118,119
and Myanmar,113 parts of India,75,79 and in recent
reports of Karen refugees upon their arrival in the
Mae La Camp on the Thai-Myanmar border.44,62
What is not currently clear is how widespread
suboptimal thiamine status is and whether
countries should be prioritizing thiamine as
a micronutrient of concern for public health
intervention programs. For instance, while there
have been several reports of infantile beriberi in
Laos, it is unclear whether the issue is localized or
widespread, andwhether it is amajor contributor to
the burden of infant mortality in the country. The
consultation group has developed a decision tree to
help guide countries on the best course of action for
investigating thiamine status and/or implementing
interventions to improve thiamine intake.
The decision tree consists of two paths: one for
those countries where there is a known high risk
of thiamine deficiency, based on beriberi or TDD
case reports, and another for those where there
may be some risk of thiamine deficiency in the
absence of beriberi reports. For the former, the
group suggests countries confirm with biomarkers
if possible and engage with stakeholders to discuss
possible interventions and monitoring programs.
For the latter, we suggest both several methods
for analyzing existing data to better understand
the risk (prevalence and severity) of suboptimal
dietary thiamine intake and implementing surveys
and/or clinical surveillance of thiamine status. This
roadmap is based on the current state of knowledge,
and it serves as a guide for public health action:
rapid assessment, diagnosis, and treatment should
continue for any individual presenting at a health
facility with clinical signs consistent with TDD.
Figure 10 provides a decision tree for countries to
consider when assessing the potential for thiamine
deficiency.
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Table 5. List of estimated thiamine intakes from studies assessing micronutrient intakes of pregnant and lactating
women in low- and middle-income countries since 1980
Continent Country Location Number of cases Method
Mean ± SD
(mg/day) Refs.
Asia
Thailand Songkhla (Southern) 236 24-h diet record
and FFQ
0.46 ± 0.14 193
Thailand Pattani 166 FFQ 0.45 (0.1–1.9
min–max)
194
Thailand Narathiwat (Southern) 400 FFQ 0.7 (0.1–2.5
min–max)
195
China Wenzhou 20 7-day diet record 0.87 ± 0.32 196
Changzhou 82 7-day diet record 0.81 ± 0.26
China Rural Southern
Mountain (Li
ethnicity)
189 5-day diet record 0.98 ± 0.38 197
Rural Southern Coast
(Li ethnicity)
76 5-day diet record 0.80 ± 0.41
China 163 24-h recall 1.77 ± 0.79 198
China Urban 479 24-h recall and
FFQ
1.2 ± 0.9 199
Indonesia Central Java 122 6−24 h recalls First trimester:
0.66 ± 0.28
200
406 6−24 h recalls Second trimester:
0.77 ± 0.24
356 6−24 h recalls Third trimester:
0.82 ± 0.33
Lao PDR Vientiane 300 24-h recall 0.8 ± 0.5 162
Nepal Bhaktapur 466 Multiple pass 24-h
recall
0.78 ± 0.23 201
India Delhi 178 2−24 h recalls 1.1 ± 0.6 202
India Haryana/Hisar
(semiarid)
30 3−24 h recalls 0.89 ± 0.2 203
Haryana/Bhiwani (arid) 30 3−24 h recalls 0.79 ± 0.2
Haryana/Kurukshetra
(wet)
30 3−24 h recalls 0.89 ± 0.1
India Ludhiana 66 Dietary survey 1.3 ± 0.2 204
India Coimbatore 316 1.2 205
India Haryana/Hisar 120 24-h recall 1.77 ± 0.76 206
India Farming 45 3-day food record
and diet habit
survey
1.3 ± 0.4 207
Nonfarming 45 3-day food record
and diet habit
survey
1.3 ± 0.3
Palau Koror 25 24-h diet recall 1.9 ± 1.0 208
Iran Maku Urban 142 2−24 h recalls and
FFQ
1.90 ± 0.73 209
Maku Rural 142 2−24 h recalls and
FFQ
2.10 ± 0.42
Continued
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Table 5. Continued
Continent Country Location Number of cases Method
Mean ± SD
(mg/day) Refs.
Africa
Burkina Faso Hounde 218 24-h recall 0.81 (P25 = 0.54;
P75 = 1.12)
210
Morocco Rural 63 FFQ 1.67 ± 0.62 211
Urban 92 FFQ 1.46 ± 0.38
Ghana Rural 15 FFQ and 24-h
recall
1.6 (0.7−2.4
range)
212
Suburban 15 FFQ and 24-h
recall
2.2 (1.3−4.6
range)
Egypt Kalama 50 Self-report and
sample
weighing
1.1 ± 0.3 213
South and Central America
Colombia Southeastern Cali 381 24-h recall 0.58 (median)
(0.42−0.85
IQR)
214
Peru Chanchamayo 206 Multiple pass 24-h
recall
0.69 ± 0.47 215
Peru Lima, Villa El Salvador 168 24-h recall 10−24 weeks
gestation: 0.8
(5th = 0.4; 95th
= 1.8)
216
120 24-h recall 28–30 weeks
gestation: 1.0
(5th = 0.4; 95th
= 1.8)
Mexico Mexico City 112 24-h recall 1.3 (1.1−1.5
min–max)
217
Brazil Sao Paulo 72 24-h recall 1.1 (0.8−1.5 IQR) 218
Chile Concepcion 214 24-h recall 1.5 (median)
(1.3-1.7 IQR)
219
Ecuador Quito 74 Survey of food
patterns and
nutrient intake
1.9 220
FFQ, food-frequency questionnaire; IQR, interquartile range.
Countries with known TDD cases. Countries
with known TDD cases may consider proceed-
ing directly to an intervention (described below).
However, it would be helpful to confirm the pres-
ence of thiamine deficiency in the population by
assessing biomarkers of thiamine status, especially
among women of reproductive age, and estab-
lishing surveillance sites in hospitals and health-
care centers to monitor the prevalence of TDDs
systematically and continuously. It is important
to note that case reports of beriberi are often
considered the tip of the iceberg in terms of
suboptimal thiamine status and an indicator of a
more widespread public health problem.
Biomarker status assessment. Biomarker status
assessment can be used to improve estimates of
severity and indicate at-risk groups within the pop-
ulation. It is also useful to generate baseline data
before interventions to assess an intervention’s effec-
tiveness. The data can also be used in conjunction
with dietary intake data to help calibrate the dosage
for potential fortification interventions.
Surveillance. For these countries, active hospital
surveillance for infantile beriberi, possibly using
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Figure 9. Comparisonof infantmortality ratesbymonthof age inCambodiabasedonDHSdata.CDHS,CambodianDemographic
and Household Survey.
sentinel surveillance sites, is an important aspect of
determining prevalence of thiamine deficiency in
regions with low thiamine intake. The consultation
group suggested conducting amedical record review
in major hospitals where TDD cases exist, or a
prospective study in these settings in searchof oneor
more key conditions associated with beriberi, such
as congestive heart failure, and response to thiamine
treatment, which may offer additional information
about potential prevalence and underdiagnosis.
Countries without documented TDD cases. For
those countries that do not have reports of docu-
mented TDD cases but where there is reason for
concern about the adequacy of thiamine intake, the
consultation group suggests that health authorities
in regional and national governments tap existing
dietary intake or food availability (FBS) data to
determine the riskof inadequate thiamine intake ina
given country. Reviewing large nationally or region-
ally representative dietary intake data can provide
insight into a population’s risk of thiamine defi-
ciency. If the results of these analyses indicate that
there is an elevated risk of thiamine deficiency, the
country may consider a more thorough assessment
and intervention, as discussed above for the coun-
tries with documented TDD cases.
Regions with low dietary thiamine intake are
obvious targets for assessments and surveillance,
and the consultation group suggested identifying
regions at particular risk by considering those
in which 50% of calories are derived from
low-thiamine staple crops like cassava and polished
rice. For example, a relatively recent analysis of FBSs
estimated that milled (white, polished) rice makes
up 1520 of the 2411 kcal/day per capita in Cam-
bodia, or 63% of daily energy supply.120 Such diets
are likely to be limited in several essential nutrients,
including thiamine. When considering the intake
of “anti-thiamine” factors, it is not known how
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Beriberi cases reported: 
- Published in the last 10 years
- Reported by pediatric society
Yes
Confirm with 
biomarkers
Consider 
assessment with 
indirect indicators
No or 
unknown
FBS/Dietary assessment:
- Low dietary diversity
- Significant calories from rice
- Consumption of anti-thiamine factors
Inadequate 
intake
Confirm with 
biomarkers
Thiamine 
deficiency is 
less likely
Adequate 
intake
and/or
Month-specific 
infant mortality 
assessment
High month 3 
mortality
Confirm with 
biomarkers
Thiamine 
deficiency is 
less likely
Typical 
mortality 
decline
Discuss possible 
interventions 
with stakeholders 
Discuss possible 
interventions 
with stakeholders 
Discuss possible 
interventions 
with stakeholders 
Figure 10. A proposed approach for assessing a country’s risk of thiamine deficiency disorders (TDDs) and the actions the
countries could consider taking to prevent or eliminate TDD cases.
much consumption is required to affect thiamine
status. However, it is well known that countries
with populations regularly consuming raw fish,
betel nuts, or silkworm larvae (A. venata) are more
likely to have TDDs, especially when combined
with a diet containing relatively low amounts of
thiamine.80 Surveillance techniques, including
dietary recall, as well as thiamine biomarker testing,
could provide greater insight into the prevalence of
subclinical thiamine deficiency in these regions.
Individual quantitative dietary assessment. Usual
thiamine intake can be assessed by quantitative
dietary intake data collected in a representative sam-
ple of the population of interest usingmethods such
as 24-h recalls, estimated or weighed food records,
or FFQs.107 The preferred assessment method
is a multiple-pass, interviewer-administered, 24-h
recall, in which individuals are asked to recall intake
over the previous 24-h period with one or more
nonconsecutive repeat days to determine the
distribution of “usual intakes in the popu-
lation” by removing intraindividual day-to-day
variation.107,121 After dietary intake data are col-
lected, thiamine intake is determined using a food
composition database, and then the dietary refer-
ence intakes can be used to assess dietary adequacy
of the population. Specifically, the percent of indi-
viduals of a given lifestage group whose usual intake
is less than the respective estimated average require-
ment (EAR) provides the prevalence of inadequate
intake in that population subgroup.121 The EAR for
thiamine for women of reproductive age and for
pregnant/lactating women is 0.9 and 1.1 mg/day,
respectively.122
Food balance sheets. As noted in Gibson and
Cavalli-Sforza’s recent publication, while detailed
dietary consumption data would be ideal to
assess thiamine intake adequacy, FBSs can be a
useful proxy in the absence of intake data.123 The
Food and Agriculture Organization of the United
Nations publishes annual FBSs to document the
amounts of various food commodities available
for dietary consumption.123 FBSs report national
food availability, not individual or household
food consumption, so regional differences in
household food security status within the country
and intrahousehold food distribution patterns may
result in an over- or underestimation of thiamine
adequacy as reflected in FBSs.124 Nevertheless, if the
FBSs indicate that there is a shortfall in thiamine
availability nationally, at least some individuals
in the population are likely to have inadequate
intakes. A recent analysis of FBSs from 17 countries
in the Western Pacific highlighted potential
dietary thiamine inadequacy in Cambodia and
Mongolia.123 A global analysis of FBSs indicated that
several countries outside Southeast Asia may also
have significant inadequacies in thiamine intake.116
These include Bangladesh, Sri Lanka, Mozambique,
Zimbabwe, Madagascar, Sierra Leone, Congo, and
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Liberia, where more than 40% of the population
was estimated to have inadequate thiamine intake.
Household consumption and expenditure survey.
A nationally representative dataset that could be
harnessed for analysis is the World Bank HCES,
which includes several subsurveys including the
Household Income and Expenditure Survey.125
With modules investigating annual household
expenditures on food and beverage commodities
(and occasionally consumption data), analysis of
this data can be useful in highlighting potential
thiamine inadequacy. HCESs have also been used
to identify potential fortification vehicles. A recent
comparison of 24-h recalls and HCES data in
Uganda found that although the HCES modeling
underestimated consumption, these models were
able to successfully differentiate consumption
patterns by life stage groups.124
Infant mortality. As described previously, an
infant mortality rate that rises around 3 months of
age rather than continuing to decline after the new-
born period is characteristic of populations with
thiamine deficiency.39 As part of an initial assess-
ment of thiamine status, a country should consider
examining available infant mortality data by month
of age to aid in its evaluation. Because beriberi is
not frequently observed until 3 months of age and
is fatal if untreated, this mortality pattern seems to
be specific to areas of thiamine deficiency.
If a country suspects that its population may be
at risk, but lacks the above data, health authori-
ties could consult with the relevant pediatric society
and/or primary healthcare providers in pediatric
hospitals to determine if cases exist but have not
been reported to higher level authorities.
Assistance from the global community. There
are also a number of actions from the global
community that may aid countries in assessing the
prevalence of thiamine deficiency. For example, the
creation of a standing thiamine technical committee
could provide technical assistance to countries in
assessing the prevalence of thiamine deficiency.
If a standing committee were created, it could
also educate decision makers more broadly about
the potential value of thiamine status assessment
and control programs. Additionally, developing a
network of resource laboratories would improve
the standardization of thiamine assessment across
laboratories, as has been done successfully for other
micronutrients, such as vitamin D.126 This network
could also support the preparation of certified
reference materials for thiamine status biomarkers
and laboratory-quality assurance schemes.
Strategies to improve thiamine status
Food fortification, supplementation, optimizing
thiamine intake from the diet, health education,
and behavior change are all important strategies for
increasing thiamine intake in regions where both
clinical and subclinical deficiencies are likely to be
widespread. This section describes the program-
matic approaches to fortification, supplementation,
dietary modification and education, and training of
healthcare workers, for countries that are aiming to
improve their population’s thiamine status.
Food fortification
Large-scale, mandatory food fortification has sev-
eral advantages: it has potential to be a sustain-
able and cost-effective intervention,38,127–129 and it
requires little or no behavior change on the part
of the consumer, as the fortificant is added to a
commonly consumed food vehicle (i.e., staple food
or condiment). Moreover, food fortification can
restore nutrients such as thiamine, riboflavin, and
iron lost during processing.130 As a population-
wide intervention, fortification offers the potential
to reach large sections of the population with rela-
tively low cost and effort.131 Large-scale fortification
holds considerable promise for increasing thiamine
status in women (and thus in breastfeeding infants).
Fortification is a sustainable, long-term solution for
combating suboptimal thiamine status and related
TDDs. Thus, the consultation group suggests that
countries with cases of TDD consider developing a
mandatory thiamine fortification program in situa-
tions where the food system is compatible with this
approach. Most often this has been done success-
fully in combination with other fortification efforts,
such as cofortification of thiamine along with other
micronutrients in wheat flour in several countries,
but it has also been done as a sole fortificant in
experimental fish sauce.108,132,133
Two forms of thiamine are used in fortification:
thiamine hydrochloride, which is the fortificant of
choice for liquid vehicles, and thiamine mononi-
trate, which is preferred for dry applications. When
fortifying with thiamine, it is important to con-
sider that both forms of thiamine are heat labile,
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are destabilized in the presence of sulfites, and are
somewhat light sensitive. The WHO has estimated
that thiamine is one of the lowest cost fortificants;
for example, $0.018 (USD) provides 100% of the
EAR for a male per day for 1 year.38
Identifying a food vehicle for fortification.
After determining that micronutrient intake is
low enough to merit a food fortification program,
national governments or regional organizations
must determine the best vehicle for delivering
that micronutrient to at-risk groups.38 Several
important considerations inform the choice of an
appropriate fortification vehicle, including dietary
consumption, technical aspects of fortification, and
scale and location of production; specific fortifica-
tion vehicles will be discussed below. Fortification
rapid assessment tool surveys anddietary intake sur-
veys canbeused to identify potential vehicles for for-
tification and appropriate levels of fortification.134
Consumption. The vehicle must be consumed
regularly throughout the year by a large propor-
tion of the population at risk of deficiency.38 While
unintended consequences, such as overconsump-
tion by segments of the population—men tend to
havehigherdietarymicronutrient consumptiondue
to unequal household food distribution—should be
taken into account, this is less relevant for thiamine
fortification as no adverse events have been reported
from excess thiamine intake, and hence, no upper
intake levels exist.122,127
Technical considerations. Choice of fortificant,
including cost and stability (degradation due to
heat, light, oxidation, moisture, and pH) of the
premix, must be considered. Ensuring there are
no adverse reactions between the fortificant and
the vehicle is also essential. Organoleptic proper-
ties must be considered, as any alteration to the
taste, smell, texture, or appearance of the food raises
the risk of consumer rejection.38,135 Fortunately, thi-
amine has no safety or sensory limitations. 136
Role of industry. Vehicles that are processed at
a centralized facility are ideal, as the presence of
multiple food production sites can complicate the
distribution of premix and quality control of final
products.38,137 “Buy in” from the relevant food
industry groups helps ensure successful fortification
with sufficient quality control.137
Implementation. There are significant costs asso-
ciated with implementing amandatory fortification
program, beyond simply purchasing the premix.
Initial start-up costs of fortification equipment and
establishment of quality control and monitoring
programsmust be considered.38 If possible, coforti-
fying an established vehicle may be an ideal means
of decreasing some of these costs.
Rice may seem to be an obvious choice of a sta-
ple for thiamine fortification in Southeast Asia, as
a recent FBS analysis from several countries in the
region indicates that rice makes up a sizeable pro-
portion of the dietary energy supply.120 However,
rice fortificationwould be challenging and costly for
several reasons. Traditional cultural practices dic-
tate that rice is typically washed several times before
cooking, which removes the micronutrients added
through powdering techniques, although extruded
or waxed fortified rice kernels are not affected by
washing.61,138 Potentially more importantly, there is
limited consolidation of rice millers in many coun-
tries. For example, nearly, every village throughout
Cambodia mills rice locally, and there are about
16,000 rice millers in Myanmar. Thus, fortification
would be highly decentralized, increasing costs and
complicating adequate quality control measures.139
Determining the level of fortification. The EAR
is the daily intake value that is estimated to meet the
physiological needs of half the healthy individuals in
a particular sex and life-stage category.140 TheWHO
recommends using the EAR cut-point method to
determine optimal levels of fortification38 to pro-
vide most individuals (97.5%) in a population
group at the greatest risk of deficiency with a total
intake that exceeds the EAR.140 The EAR cut-point
approach requires knowing the target population’s
usual intakes of both the fortification vehicle and
the micronutrient of interest.38 At the moment,
there are limited detailed dietary data available for
any of the countries where TDDs are well doc-
umented. Before fortification programs are intro-
duced, detailed data on usual consumption of both
potential food vehicles and thiamine are required to
optimize the level of fortification, ensure safety, and
minimize cost.
Food vehicles for thiamine fortification.
Wheat flour fortification. Wheat flour is fortified
with thiamine in many countries, including the
United States and Canada, the UK, Indonesia,
Jordan, South Africa, and some Central Asian
countries.132,141,142 Despite thiamine’s sensitivity to
29Ann. N.Y. Acad. Sci. 1430 (2018) 3–43 C© 2018 The Authors. Annals of the New York Academy of Sciences
published by Wiley Periodicals, Inc. on behalf of New York Academy of Sciences.
Thiamine deficiency–intervention roadmap Whitfield et al.
heat and light, breads and pasta made with fortified
wheat flour retain more than 70% of thiamine after
baking or cooking.38 Wheat flour fortification with
thiamine is feasible in areas of South Asia where
thiamine deficiencies are prevalent, particularly
because costs are low. However, if a local population
consumes very little wheat overall, as in many
Southeast Asian countries, or wheat milling is
decentralized, fortification of other staple food
vehicles or condiments may be necessary to assure
adequate thiamine consumption. Wheat consump-
tion should be more closely monitored in future
fortification efforts, especially in Southern Asia.
Fishand soy sauces. Fish saucehas shownpromise
as a vehicle for thiamine fortification. In parts of
Southeast Asia, the condiment is widely used and
readily consumedby young children and adults alike
at most meals. Any bacterial thiaminases associ-
ated with fish gastrointestinal tracts appear to be
denatured in thepasteurizationprocesses. Thiamine
added after pasteurization causes no organoleptic
changes, and a thiamine-fortifiedfish saucehas been
tested in Cambodia. Two small, concurrent ran-
domized controlled trials of thiamine-fortified fish
sauces (one sauce fortified at 2 g/L, one at 8 g/L, and
one control sauce) were conducted over 6months in
Prey Veng province, Cambodia. After perinatal con-
sumption of thiamine-fortified fish sauce, moth-
ers and their exclusively breastfed infants showed
improvements in eThDP and breastmilk thiamine
levels over a 6-month period.100 In a second cohort
of rural Cambodian mothers and their children <5
years, those in the thiamine-fortified groupshad sig-
nificantly higher eThDP compared with the control
group.108 Fish and soy sauces have been established
as vehicles for iron fortification in Cambodia,143,144
Vietnam,145,146 and Thailand.147 It is likely that thi-
amine could also be added to these condiments
at low additional cost, but further investigation is
needed to determine the most regionally relevant
vehicle for each country, with considerations for
consumption and centralized production. Decen-
tralized production may be the major barrier; for
instance, as February 2014, there were 42 registered
producers fortifying fish and soy sauce with iron in
Cambodia.148
Salt. Salt fortification with iodine has been
implemented in more than 120 countries, and its
use has dramatically reduced iodine deficiency
disorders in many parts of the world.149 Salt is
under consideration as a vehicle for additional
micronutrient fortification and could be a promis-
ing vehicle for thiamine fortification.150 A trial of
multiple micronutrient-fortified salt (including
2 mg thiamine/10 g salt and 10 other microencap-
sulated micronutrients) in Indian school children
showed that the multifortified salt retained ade-
quate nutrient content after 20 min of cooking time
and lost only 0.52% of thiamine. After 6 months
of storage at 30 °C and 45% relative humidity, the
fortified salt retained 96% of the thiamine original
content.151 While no assessment of thiamine status
was performed, indicators of vitamin A, iodine,
and riboflavin (vitamin B2) deficiency were signif-
icantly reduced after 12 months of consuming the
multifortified salt. Despite this promising evidence,
salt requires more investigation as a vehicle for
fortification. Recent data fromCambodia show that
a lack of donor support for iodine premix and/or
a suboptimal monitoring and quality control
program have resulted in a decrease in iodized salt
use (38% of salt samples in 2014, down from 78%
in 2011).152 This highlights the importance of con-
tinued government and donor support to ensure
the sustainability of any fortification program.
Rice fortification. Rice is the dietary staple in
many of the countries where TDDs are known to
be prevalent, and as such should be considered
as a potential fortification vehicle. The suggested
approaches for rice fortification per the Food Forti-
fication Initiative are:
1. Coated rice kernels, accomplished by apply-
ing a thiamine-enriched mixture of waxes to
rice kernels and mixing fortified kernels with
polished rice in a ratio of 1:50−1:200; or
2. Mixing extruded, enriched, rice-shaped ker-
nels (made by hot extrusion from a rice flour
andvitamin/mineral premix)with typical pol-
ished rice in a similar ratio.
Both approaches maintain thiamine content
through cooking; however, fortified rice kernels pro-
duced by powdering techniques appear to be more
vulnerable to washing.153
Rice fortification faces several challenges in
LMIC. Rice is often sourced from multiple local
millers, and fortification efforts that rely on many
different producers are generally viewed as less
viable. Rice fortification also requires specialized
equipment, which limits industry uptake. Indeed,
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data from the Fortified Rice Project, a pilot forti-
fication program in Myanmar, show that only one
local miller was equipped with an extruder to pro-
duce fortified rice-shaped kernels, and only eight
(of some 16,000) millers are fortifying rice. Further,
the fortificants used to enrich rice may be destroyed
if rice is stored at high temperatures. Despite these
concerns about using rice as a vehicle, rice fortifica-
tion may still be practical in some situations, such
as when food is distributed during emergencies or
through food aid programs, where the challenges of
decentralized milling do not apply.
Monitoring andquality control is key. It is essen-
tial to address monitoring and quality assurance
fromthe earliest stages of programplanning, includ-
ing measures to take appropriate actions on low
compliance food producers. Several recent pro-
grams fromvarious LMIC indicate that a lack of reg-
ular quality assurance measures to ensure adequate
fortification and/or monitoring and follow-up of
health outcomes can undermine the success of the
programs in the long term.137,152 Attention should
also be paid in the presence of multiple producers
of food vehicles in the country, on how tomaximize
the monitoring and quality control of adequate for-
tificant level.
Biofortification. Biofortification—use of con-
ventional plant breeding methods, agronomic
approaches, or genetic engineering to increase
the micronutrient content of a plant—is another
method of increasing dietary intake of a
micronutrient.154 Goyer recently developed a rice
cultivar that overexpresses the genes THIC and
THI1, which results in a fivefold higher thiamine
content.155 However, the thiamine is found primar-
ily in the husk, which, as stated above, is removed
during polishing. There was also a small increase
in endosperm thiamine, which contained 1.3 times
higher thiamine compared with wild-type rice. Thi-
amine biofortification is not a viable public health
approach to TDD prevention at the moment, how-
ever. Research in this area is ongoing.
Supplementation
Thiamine supplementation guidelines have focused
on emergency situations, most often when conflict
or famine results in food insecurity for large
numbers of refugees or displaced persons. Infantile
beriberi outbreaks are well documented in such
populations, for example, in the Karen refugee
population in Thailand.44 In these cases, the
addition of thiamine-rich foods to emergency aid
rations or the delivery of thiamine supplements is
recommended and has proven effective in reducing
or eliminating cases of infantile beriberi.44 In the
clinical setting, patients treated for beriberi are
given thiamine supplements for approximately
1 month following recovery. Few nonemergency
thiamine supplementation programs have been
implemented. One such program, the Infantile
Beriberi Project in Myanmar, offers 10 mg of daily
thiamine supplements to pregnant and lactating
women from the final month of pregnancy through
the first 3 months of lactation. It is essential to
monitor and evaluate the programs on an ongoing
basis, both for program coverage and recipient
adherence to the supplementation regimen.
Supplementation of pregnant and lactating
women. Based on current knowledge, infantile
beriberi is the most severe adverse outcome of sub-
optimal thiamine status; clinical symptoms develop
more quickly among infants than adults due to the
rapid growth and development that occurs at this
life stage relative to dietary intake.156 Without rapid
thiamine administration, infants can die of infantile
beriberi within hours of clinical presentation.44
Infantile beriberi presents during the exclusive
breastfeeding period as a result of consuming
thiamine-deficient breastmilk from mothers with
low thiamine status.48,156 Since breastmilk is rec-
ommended as the sole source of nutrition for
infants under 6 months,157 maternal dietary thi-
amine intake must be improved to prevent infantile
beriberi and related mortality.61
Maternal thiamine supplementation has been
shown to successfully prevent suboptimal thiamine
status among Karen refugees in the Mae La
camps44,158 and has also been shown to improve
breastmilk thiamine concentrations during research
projects in rural Cambodia,100,109 the Gambia,159
and India.160 Results of a recent study in Prey
Veng, Cambodia, suggest that improved maternal
thiamine intake in the third trimester of pregnancy
allows for fetal uptake in utero,100,161 highlight-
ing the importance of adequate status in both
pregnancy and lactation. This is further supported
by a thiamine pharmacokinetics study that found
significant increases in breastmilk thiamine after
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5 days of maternal supplementation, although this
was not sufficient time to increase infant whole
blood ThDP or plasma thiamine concentrations.109
Countries with reports of infantile beriberi or
evidence of low biochemical thiamine status should
consider either the addition of a thiamine supple-
ment to complement the current perinatal iron-folic
acid supplementation program, or should intro-
duce a multiple micronutrient supplement con-
taining thiamine, such as the UNICEF/WHO/UNU
international multiple micronutrient preparation
(UNIMMAP). With any indication that dietary thi-
amine intake is low in a given population, the con-
sultation group suggests considering switching from
the standard iron-folic acid supplementation regi-
men inpregnancyand lactation toone including thi-
amine or the UNIMMAP formulation to reduce the
risk of infantile beriberi, a practice that was adapted
by Myanmar in 2016.
Thiamine status of a breastfed infant is closely
linked to that of the mother, so improving thiamine
status of lactating women is a logical approach
to prevent infantile beriberi. However, additional
research is needed to establish the optimal timing,
dose, and duration of maternal supplementation.
Adding thiamine to an existing supplementation
program could be an easy and cost-effectivemethod
to improve thiamine status of pregnant and lactating
women.
Multiple micronutrient powders. In many
countries, infants older than 6 months of age
receive multiple micronutrient powders (MNP)
that include thiamine, and could be used as a
method to increase thiamine status. While the
impact of this intervention on thiamine specifically
has not been documented, it is likely to improve
status and functional outcomes. A straightforward
intervention that may be tested to lower the
prevalence of thiamine deficiency in children is the
use of MNP for home fortification.
Behavior change
Changing dietary patterns to increase the consump-
tion of thiamine-rich foods, and limit the intake
of known thiamine antagonists and thiamine-poor
foods, could improve thiamine intake. Nutrition
[Correction added on August 28, 2018, after first online
publication: The word “agonists” has been replaced with
“antagonists” throughout.]
education and behavioral change communication
on promoting dietary diversity with nutrient-rich
foods are essential to changing dietary patterns. In
some countries like Myanmar, ideas about avoid-
ing specific foods are still common for pregnant
and lactating women that result in limited intake
of nutrient-rich foods and increase the risk of defi-
ciencies. In a cross-sectional survey in Vientiane,
Lao, Barennes et al. found that 93% of women
(n = 274/300) practiced postpartum food restric-
tion (phit kam). It was common for women to con-
sumeonly a traditional herbal tea for thefirst 15days
postpartum (n = 285/300; 95%), which translated
to an estimated mean (95% CI) thiamine intake
of 0.4 (0.1−0.7 mg/day) intake during this period
(dietary intake n = 31, days 1−15, 24 h recall).163
Raising awareness of the consequences of local food
avoidances in pregnant and lactating women and
promoting thiamine-rich alternatives can improve
maternal thiamine intake.
As noted above, in populations where white, pol-
ished rice is the main dietary staple, thiamine is
lacking not only becausewhite rice is thiamine poor,
but also because the sheer volume consumed limits
the consumption of thiamine-rich foods. Parboil-
ing rice can increase thiamine content of polished
rice by leeching thiamine from the bran into the
endosperm. Additionally, traditional food process-
ing techniques such as fermentation can also be pro-
moted in the nutrition education message, as it can
increase the level of thiamine and other B vitamins
in the plant-based diets.164
Providing nonspecific nutrition education mes-
sages will likely not have a significant effect on the
population’s thiamine intake or status. Rather in
LMIC, the promotion of locally available nutrient-
rich foods could be considered as an alternative
to optimize thiamine intake as well as to tackle
the coexistence of multiple micronutrient deficien-
cies. Identifying context-specificnutrient-rich foods
and supporting their intake may be useful, espe-
cially in resource-poor countries as a long-term and
sustainable strategy. An approach known as Lin-
ear Programming is available to identify the prob-
lem nutrients in the diet of the population, to
formulate the food-based recommendations that
resemble the current dietary practices, and to fill
the nutrient gaps. This approach considers multi-
ple factors, such as existing dietary pattern, nutrient
content of foods, food cost, and cultural factors, and
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Figure 11. Educational poster outlining common signs of infantile beriberi (in Khmer).
hence reduces the challenge for the population to
totally change their current dietary practices.165–167
Food processing and consumer behaviors
Food processing changes also have the potential to
affect the thiamine content of various foods. Rice
processing and consumption is particularly impor-
tant because, as detailed above, TDD often appears
in regions where polished rice is a dietary staple.
In most rice-consuming countries, well-polished
white rice is preferred for various reasons, includ-
ing cultural (e.g., white rice is a status symbol,61
it has optimal organoleptic properties) and eco-
nomic (e.g., removal of the lipid-rich outer bran
increases shelf-life,168 and less fuel and water is
required for cooking).168,169 There are also eco-
nomic incentives for rice millers to polish rice
thoroughly, as rice bran is a major animal feed
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product in Southeast Asia.170,171 Anecdotal evidence
from rural Cambodia suggests that local rice millers
do not charge famers to mill rice, but rather are
allowed to keep the rice polishings, which they sell
as animal feed.With thismodel, it is in the best inter-
est of the ricemiller to fullymill the husk andbran of
the rice to maximize the weight of animal feed they
can sell.
Parboiled rice. While rice naturally contains thi-
amine in its outer husk and bran (aleurone layers),
the practice of milling away those layers, or “pol-
ishing,” to produce shelf-stable white rice renders it
very low in thiamine. Parboiling rice before milling
reduces this loss, allowing some migration of thi-
amine from the aleurone layer to the endosperm.
It has been estimated that approximately 50% of
rice produced is parboiled, but with very inhomo-
geneous global coverage.162 Unfortunately, parboil-
ing rice is not commonplace in Southeast Asia,
as this process traditionally resulted in a musty
aftertaste caused by mold growth during long-
term solar drying. Today, parboiled rice is dried in
commercial driers; and, while taste is unaffected,
this process causes a darkening of the endosperm,
which decreases consumer acceptability.
Thiamine antagonists. Consumption of foods
containing thiamine antagonists, such as certain
fish species and larvae of the African silk worm
(as described above), is also thought to contribute
to the development of TDD. Thiaminases are heat-
liable, so recommendations to consume thiaminase-
containing foods cooked rather than raw should
ameliorate deficiency.156 The effects of gallic acid-
containing tannins, such as those found in tea and
betel nuts,172 can be prevented by delaying contact
between thiamine and tannins (e.g., consuming tea
hours after a thiamine-containing meal, rather than
during the meal).173
Interventions to alter current food processing
practices and consumption patterns may improve
the thiamine content of diets. For instance, incen-
tivizing rice millers to remove less rice bran,
or developing improved storage technologies to
increase the shelf life of brown rice, could improve
the thiamine intake of rice consumers. Consumer
education is also important: addressing and explain-
ing the benefits of parboiled rice could increase
acceptability despite darkened kernels, or simply
advising not to drink tea with meals could help pre-
vent thiamine degradation.
Education of healthcare providers
As noted above, TDDs are often under-recognized
by clinicians, leading to missed or delayed diagno-
sis. In addition, it is not uncommon for infants to
present with beriberi while their mothers remain
asymptomatic.13,119,156
We suggest that countries with known cases of
TDDconsiderdeveloping culturally relevanthealth-
care provider education tools to help identify, treat,
and prevent suboptimal thiamine status. A recent
trial in Cambodia employed a local artist to develop
a poster outlining the common signs of infantile
beriberi for study participants and to raise aware-
ness of infantile beriberi symptoms (Fig. 11). While
this tool was originally designed to educate study
participants about the signs of thiamine deficiency,
it was also shared with local village health volun-
teers and village chiefs to increase awareness of
infantile beriberi. Alternatively, video clips showing
the appropriate assessment, diagnoses, treatment,
and importantly the recovery of infants present-
ing with beriberi may be extremely helpful train-
ing tools for healthcare practitioners. Professional
training and in-service refresher courses for health-
care providers in settings where thiamine deficiency
occurs should provide information on promoting
appropriate dietary habits and counseling pregnant
and lactating women not to avoid thiamine-rich
foods.
Research opportunities
As described throughout this report, there are a
number of unknowns regarding assessment, preva-
lence, treatment, and the health effects of thiamine
deficiency. These are summarized in Table 6 as a
list of thiamine “research opportunities” elaborated
by the consultation group during a series of dis-
cussions. Resolving these issues will increase under-
standing of TDDs and improve the ability to identify
and prevent them.
Conclusions
Thiamine deficiency and its clinical manifestations
as TDDs may be quite common in many regions of
the world, especially in LMIC. A number of pop-
ulations around the world are at risk of thiamine
deficiency based on low dietary intakes, resulting
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Table 6. Thiamine research opportunities
Biomarkers
Current laboratory reference ranges for thiamine diphosphate (ThDP) are based on the range of thiamine status in
populations without thiamine deficiency, and there are no commonly accepted clinically relevant cut-points for thiamine
deficiency based on ThDP. A more appropriate cutoff for deficiency should consider clinical manifestations of thiamine
deficiency in at-risk populations to better assess and define thiamine deficiency.
Research need: Establish deficiency cutoffs for ThDP that are relevant to populations with endemic thiamine deficiency.
Comparing the different biomarker data for thiamine deficiency is currently challenging because there are few studies relating
blood ThDP concentrations to the corresponding erythrocyte transketolase activation coefficient (ETKAC) values.
Additionally, there are no published data comparing the biomarkers in a deficient population. As both biomarkers are
currently used, understanding their interrelationship is important for comparing data from different studies.
Research need: Determine the relationship between whole blood/erythrocyte ThDP concentrations and ETKAC.
There are a number of challenges to assessing thiamine status in low- and middle-income countries (LMIC), including the
required cold chain and limited availability of laboratories to analyze thiamine status.
Research need: Development of point-of-care diagnostics for rapid assessment of thiamine status.
Thiamine deficiency disorders
Owing to the wide variability in clinical presentations, TDDs do not have standardized case definitions.
Research need: Develop a set of standardized case definitions for TDDs.
Based on the long-term follow-up of the Israeli children who received infant formula that was inadvertently lacking thiamine,
it appears that there are long-term neurological effects of short-term thiamine deficiency. Long-term adverse effects on
neurodevelopment were even identified in children with subclinical deficiency.
Research need: Determine the long-term effects of subclinical thiamine deficiency.
Current strategies to reduce infantile beriberi include maternal thiamine supplementation, which successfully increases the
thiamine content in breast milk. However, long-term effects of such an intervention on the children have not been studied,
especially with respect to their neurocognitive development.
Research need: Evaluate the effects of maternal thiamine supplementation on long-term neurocognitive outcomes in infants.
Thiamine deficiency prevalence
Thiamine status is rarely assessed in LMIC, making estimates of the prevalence of deficiency difficult. Improving these
estimates would help identify areas where interventions are most needed.
Research need: Increase the incorporation of thiamine status assessment in population-based nutrition and health surveys.
Thiamine deficiency prevention
Some maternal thiamine supplementation programs end 3 months after birth and do not cover the remaining period of
exclusive breastfeeding. The lowest effective dose of supplementation has also never been established.
Research need: Identify the necessary dose and duration of maternal thiamine supplementation to prevent infantile beriberi.
In many countries, infants older than 6 months of age receive micronutrient powders (MNP) that include thiamine. The
impact of this intervention on thiamine status has not been well documented, but it is likely to improve status.
Research need: Assess whether MNP improve thiamine status and functional outcomes associated with thiamine, such as
language skills or cognitive development.
Patients with severe acute malnutrition (SAM) treated in healthcare centers are often critically ill and may have multiple
comorbidities. Since thiamine requirements are increased in critically ill patients, there is a high risk of thiamine insufficiency
in these SAM patients.
Research need: Determine the appropriate dose of thiamine for the treatment of SAM and specifically the dose that is used in
F75 milk, during the early phases of refeeding.
35Ann. N.Y. Acad. Sci. 1430 (2018) 3–43 C© 2018 The Authors. Annals of the New York Academy of Sciences
published by Wiley Periodicals, Inc. on behalf of New York Academy of Sciences.
Thiamine deficiency–intervention roadmap Whitfield et al.
primarily from subsistence on low-thiamine staple
grains. Assessing the thiamine status of populations
in these areas shouldbe apriority.Withnewresearch
suggesting that even subclinical deficiency may
impair neurocognitive development, there is reason
tobehighly concerned about thiamine insufficiency,
even in areas where clinical beriberi may be uncom-
mon. While treatment of confirmed or suspected
beriberi with thiamine is rapid and safe, the het-
erogeneity of symptoms makes thiamine deficiency
difficult to identify, suggesting that the prevalence
of TDDs may be vastly underestimated. The use
of available biomarkers needs to be expanded
to provide better information on the prevalence
of deficiency and determine if interventions are
necessary. However, reported cases of TDD is a
strong indication of thiamine deficiency among
the population, and an intervention is likely
required. In such cases of known or suspected
thiamine deficiency, there are a number of possible
interventions, including food fortification and
supplementation of pregnant and lactating women
and of young children.
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